Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Cytosorbents Corporation - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
CTSO
Nasdaq
3841
www.cytosorbents.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Cytosorbents Corporation
CytoSorbents to Present at the H.C. Wainwright 28th Annual Global Investment Conference
- Sep 10th, 2026 5:00 am
CytoSorbents to Present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference
- Sep 4th, 2026 7:09 am
CytoSorbents Announces Reverse Stock Split
- Sep 3rd, 2026 5:00 am
CTSO: CytoSorbents Announces Very Positive New Real-World Data Demonstrating Significant Reduction in Severe Bleeding Using CytoSorb in CABG Patients on Ticagrelor
- Sep 3rd, 2026 3:31 am
CytoSorbents Announces New Real-World Data Demonstrating Significant Reduction in Severe Bleeding Using CytoSorb in CABG Patients on Ticagrelor and Updates Recent DrugSorb-ATR FDA Pre-Submission Meetings
- Sep 2nd, 2026 5:28 am
CTSO: CytoSorbents Future Value Drivers Support Price Target of $4.00
- Aug 17th, 2026 4:06 am
Cytosorbents (CTSO) Q2 2026 Earnings Call Transcript
- Aug 13th, 2026 5:29 pm
Cytosorbents Corporation Q2 2026 Earnings Call Summary
- Aug 7th, 2026 6:30 am
CytoSorbents Corp (CTSO) (Q2 2026) Earnings Call Highlights: Nearing Breakeven with Strong ...
- Aug 6th, 2026 11:08 pm
CytoSorbents Reports Second Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update
- Aug 6th, 2026 2:25 pm
CytoSorbents to Report Second Quarter 2026 Financial Results and Recent Business Highlights
- Jul 20th, 2026 5:00 am
OTC Markets Life Sciences Investor Forum: Dr. Phillip Chan, CEO, and Pete Mariani, CFO, of CytoSorbents with Zacks SCR’s Tom Kerr, CFA
- Jul 8th, 2026 4:02 am
Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing
- Jun 26th, 2026 6:35 am
Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th
- Jun 23rd, 2026 6:35 am
CytoSorbents to Present at the Life Sciences Forum on June 24, 2026 and Meet Virtually with Investors on June 30, 2026
- Jun 18th, 2026 6:46 am
CTSO: CytoSorbents Reports 1st Quarter Financial and Operating Results
- May 21st, 2026 11:03 am
Cytosorbents Corporation Q1 2026 Earnings Call Summary
- May 14th, 2026 6:30 am
CytoSorbents Corp (CTSO) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic ...
- May 13th, 2026 11:02 pm
Scroll